Transcript Slide 1

Scalable Digital Pathology in a
Large, Preclinical Organization
Luc Chouinard, DVM, DACVP
Scientific Director, Pathology
OVERVIEW
• Charles River Preclinical Services
• Current use of Digital Pathology in CRO
• Future applications
Charles River Snapshot
• A leading in vivo biology company
– $1.34B in net sales (FY 08)
• Unique portfolio of products and
services focused on the research
and development continuum for
new drugs
• A multinational company with
~8,700 employees worldwide
– ~70 facilities in 17 countries
Corporate Headquarters
Wilmington, MA
CR Global Footprint
Existing Pharma /
Biotech Cluster
Emerging
Market
A global presence with proximity to our clients’ sites
4
Charles River Preclinical Services
PRECLINCAL/DISCOVERY Sites – Overview
• PCS
–
–
–
–
–
–
–
–
Montreal – full service, all species, some disease models
Shrewsbury – full service, all species, some disease models
Edinburgh – full service, all species, non-pharma services
Nevada – historically only primates (inc repro), now offering rodent
and dog toxicology, safety pharmacology, lab sciences
Pennsylvania – reprotoxicity, phototoxicity, neurotoxicity
Ohio – general toxicology, carcinogenicity
China– all species (initially ≤ 3 mo), GLP and non-GLP
Sherbrooke – all species, mainly general toxicology
– PAI –Complete pathology services
• DIS
– MIR – imaging, oncology/inflammation rodent models
– Piedmont – oncology models
– Ceribricon- CNS rodent models
Charles River Pathology Services
• More pathologists than any other company in the
world
•



Assessment of pathologic changes in:
Drug discovery
Toxicology
Animal colony maintenance
Value of digital pathology services for
sponsors
• Allow sharing/consultation across sponsor and
CRO pathologists
• Be aware of potential adverse findings earlier
• Better understanding of the toxicity profiles by
making comparisons easier
• Avoid inefficient sharing of partial images or
lengthy discussion (via teleconference) to
describe a finding
• Reduce costs and time delays in pathologist
travel and shipping of slides
• Allow sharing with consultants
Value of digital pathology for CRO
•
•
•
•
•
•
Further enhances client relationships
Enhance consistency
Improve training
Improve standardization
Improve productivity
Cost saving
CRO Preclinical Pathology Challenges
•
•
•
•
Quest for faster reporting and effectiveness
Shorten turnaround time for consultations
Limiting travel for peer review on site
Avoid days or weeks for the transportation of
glass slides
• Potential issues with border/custom and
international laws
PCS MTL experience
• Installation of a high capacity scanner Q1 2008
PCS MTL number
•
•
•
•
•
17 Pathologists
1.5 M tissues processed/year
35 000- 45 000 slides prepared/months
Average 6 peer review/week
3 on site; 3 ship to sponsor
PCS MTL Digital Pathology Team
• 3 administrators
• Manage the Internal and Client accounts.
• creating user and/or administrator accounts
• assigning access levels
• password administration
PCS MTL Digital Pathology Team
• Manage scan requests and all steps towards
generation of the virtual images for users
• Contact material preparation group for slides
access and ensure adequate slide condition prior
to scanning
PCS MTL Digital Pathology Team
• Contact the pathologists and clients with access
info
• Help desk/trouble shooting with clients
• Responsible for deleting images/slides on servers
as per guideline
PCS MTL Digital Pathology Workflow
Metada and Laboratory information
system
Local IT solution
Interfacing to laboratory information systems
SLIDE LOADER 1.0.1
• No Barcoded slides!
• Metadata transfer from two sources
Proventis (LIMS) and PLS form (histology lab database)
Slide loader 1.0.1
Metadata transfer - interdepartmental
information –systems-applications
GUIDELINES
• PROCESS FLOW FOR SCANS
• REQUEST FOR SCANS
• MATERIAL PREPARATION GROUP - SLIDE
RETRIEVAL AND LOADING
• MANUAL SCANS
• AUTOMATIC SCANNING
• TRACKING OF REQUESTS FOR SCANS
• DIGITAL SLIDE CONFERENCING
• DELETING IMAGES
• TROUBLE SHOOTING NOTES
PCS MTL Data since installation
Total slides scanned
3500
3000
2500
Internal
2000
Client related
1500
1000
500
0
2008
2009
PCS MTL Data since installation
•
•
•
•
•
More than 4000 slides scanned
200 requests
85 % client related
Slides scanned from 155 projects
95% reduction of internal photomicrography
needs
Current use
• External Consultation
• YES
• Internal Training & Meeting
• YES
• QC
• YES
• Formal Complete Peer Review
• NO
• Full tissue complete GLP study
evaluation
• NO
PCS MTL experience
Scanning protocols
 Not routine for all sponsors or projects
 Case by case needs for the majority
 Scan selection of tissues, targets or unusual
changes for discussion in the majority of the
cases.
 Generally limited to 10-30 slides/study.
 Scan of all tissues in preterminal death in a few
occasions
PCS MTL experience
Improved Pharma-CRO partnership
Pre-study or pre-report meeting (TC, Web)
Review\Discuss\Share Slides
 Key findings
 Previous studies
 Potential targets
 Glossary
 Grading
Toxicity Study Dose Group Comparison
Toxicity Study Dose Group Comparison
Toxicity Study: Terminology and Grading
Challenges
• Acceptance
• GLP & Implementation & Validation
STP position paper Pathology Image Data
STP position paper Pathology Image Data
 Pathology images (printed, electronic, or digital)
used for data generation (e.g., to make a
diagnosis or for morphometric analysis) are raw
data that must be authenticated and archived.
Important notes from the STP position
paper
During an informal pathology review, the opinions of any consulting
pathologists are not binding on the study pathologist.
The preamble to the GLP Regulations, as amended on September
4, 1987, and published in the Federal Register (Volume 52,
No. 172, pages 33768-33782), states that:
“. . . . pathologists interim notes, therefore, which are subject to
frequent changes as the pathologist refines the diagnosis, are not
raw data because they do not contribute to study reconstruction
Accordingly, only the signed and dated final report of the pathologist
comprises raw data respecting the histopathological evaluation of
tissue specimens.”
STP position paper Pathology Image Data
Informal Consultation
Informal pathology consultation before
the pathology report is completed is a
common practice in toxicologic
pathology.
Informal discussions and any associated
images are not pathology raw data
Future of Digital Path in CRO
•
•
GLP use
Enhance use of automated function and analysis
Hematology
Immunohistochemistry
Morphometry
Histology pattern recognition-CAPS
The future of Digital Pathology
Summary
• The introduction of digital pathology in a large
CRO had an immediate and significant impact
despite current limitations and challenges
Improved
• Efficiencies
• Partnership
• Training
• Overall Quality of Services
Summary
The future is promising!
Acceptance and new automated applications will
modify the role of pathologists to further facilitate
interpretation and improved translational
toxicology
Thank you